CCL19 and neoplasm: By analyzing the co-occurrence patterns of cell states, we have uncovered tumor-specific rewiring of interferon-enriched community which comprise TLS components including CCL19+ fibroblast and LAMP3+ DC that hold distinct clinical significance in immunotherapy-treated cohorts (n = 1261), including our lung cancer (LC) cohort (n = 497).